CRISPR-Cas based rapid diagnostics of Miltefosine susceptible and resistant strains of Leishmania donovani from asymptomatic and post kala azar dermal leishmaniasis using invasive and non- invasive approach
Funding Agency : ICMR
Ongoing
Co Principle Investigator
2179660
2022 -
continue
CRISPR-Cas based rapid diagnostics of Miltefosine susceptible and resistant strains of Leishmania donovani from asymptomatic and post kala azar dermal leishmaniasis using invasive and non- invasive approach